A

AbCellera Biologics
D

ABCL

3.04000
USD
-0.11
(-3.34%)
Market Closed
Volume
63,531
EPS
-1
Div Yield
-
P/E
-5
Market Cap
897,913,491
Related Instruments
    AAPL
    AAPL
    -0.310
    (-0.13%)
    245.560 USD
    AMZN
    AMZN
    -6.305
    (-2.83%)
    216.495 USD
    CRM
    CRM
    -8.64
    (-2.71%)
    309.78 USD
    GOOGL
    GOOGL
    -4.895
    (-2.65%)
    179.685 USD
    MSFT
    MSFT
    -7.96
    (-1.91%)
    408.15 USD
    NFLX
    NFLX
    -22.12
    (-2.16%)
    1,002.42 USD
    TSLA
    TSLA
    -16.87
    (-4.76%)
    337.50 USD
    More
News

Title: AbCellera Biologics

Sector: Healthcare
Industry: Biotechnology
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to theclinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.